Date: Thu, 18 Dec 1997 18:02:03 GMT
Server: NCSA/1.5.2
Last-modified: Fri, 05 Dec 1997 15:41:39 GMT
Content-type: text/html
Content-length: 2382

<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html>

<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage 3.0">
<title>T Cell Sciences Company Information</title>
</head>

<body bgcolor="#FFFFFF" text="#000000">

<h1><img src="../../graphics/tcell_logo85.gif" align="right" hspace="0" width="166"
height="44">Company Information</h1>

<hr>
<b>

<p>T Cell Sciences, Inc.</b> is a biopharmaceutical company creating value by using novel
applications of immunology to prevent and treat cardiovascular, pulmonary and immune
disorders. The company is engaged in discovery and early clinical development of three
therapeutic programs. The most advanced clinical program focuses on developing compounds
that inhibit the inappropriate activation of the complement cascade in a variety of acute
and chronic diseases. The company is engaged in the discovery of T cell activation
regulators for the prevention of transplant rejection and treatment of autoimmune
disorders. The company&#146;s third program targets the development of a vaccine for the
management of atherosclerosis, one of the leading causes of death in the world.</p>

<hr>

<dl>
  <dd><a href="management_info/management.html"><img src="../../graphics/tcell_small.gif"
    align="top" border="0" width="35" height="36"></a> <a
    href="management_info/management.html">T Cell Sciences Management</a></dd>
  <dt>&nbsp;</dt>
  <dd><a href="financial_info/financial.html"><img src="../../graphics/graph.gif" align="top"
    border="0" width="32" height="32"></a> <a href="financial_info/financial.html">Financial
    Information</a></dd>
  <dt>&nbsp;</dt>
  <dd><a href="shareholder_letter.html"><img src="../../graphics/tcell_small.gif" align="top"
    border="0" width="35" height="36"></a> <a href="shareholder_letter.html">Letter to
    Shareholders from 1996 Annual Report</a></dd>
  <dt>&nbsp;</dt>
  <dd><a href="../press_releases/1997press/111497letter.html"><img
    src="../../graphics/tcell_small.gif" align="top" border="0" width="35" height="36"></a> <a
    href="../press_releases/1997press/111497letter.html">Letter to Shareholders, November 14,
    1997</a></dd>
</dl>

<hr>

<p align="center"><a href="../../index.htm"><b>T Cell Sciences Home Page</b></a></p>
</body>
</html>
